Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$145,792
in 2 filings, $146K under 10b5-1 plans

Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-30 Katkin Keith Director Grant or award 10b5-1 +25,344 111,775
2026-04-30 Katkin Keith Director Sale 10b5-1 −15,481 $8.28 $128K 96,294
2026-04-30 Katkin Keith Director Grant or award · Stock Options (Right to Buy) 10b5-1 +11,296 11,296
2025-05-23 Katkin Keith Director Sale 10b5-1 −7,844 $6.30 $49K 86,431
2025-04-30 Katkin Keith Director Grant or award +34,403 94,275
2025-04-30 Katkin Keith Director Grant or award · Stock Option (Right to Buy) +15,824 41,572
2024-05-23 Katkin Keith Director Grant or award +17,430 59,872
2024-05-23 Katkin Keith Director Grant or award · Stock Option (Right to Buy) +25,748 25,748
2023-05-25 Katkin Keith Director Grant or award +33,847 42,442
2022-04-02 Katkin Keith Director Grant or award +8,595 8,595

Page 1 of 1 · 10 trades